Skip to main content
. 2017 Jun 29;15:149. doi: 10.1186/s12967-017-1248-y

Fig. 2.

Fig. 2

ROC curves for OXR1, OXR1&MST1R and HOXA9 promoter methylation levels in different clinical settings. ROC curves for clear cell renal cell carcinoma (ccRCC) versus the remaining renal cell tumours (RCT) for OXR1 (a) and for OXR1&MST1R (b), and for oncocytoma versus papillary (pRCC) and chromophobe (chRCC) renal cell carcinoma for HOXA9 (c)